期刊文献+

PTEN、NF-κBp65和CyclinD1在胃腺癌中的表达及其与肿瘤临床病理间的相关性 被引量:2

Expressions of PTEN,NF-κBp65 and CyclinD1 in Gastric Adenocarcinoma and Their Correlations with Clinicopathologic of the Tumor
下载PDF
导出
摘要 背景与目的:探讨PTEN、NF-κBp65和CyclinD1在胃腺癌组织中的表达及其与肿瘤临床病理特征之间的相关性。材料与方法:用免疫组织化学S-P法检测73例胃腺癌及20例正常胃粘膜组织中PTEN、NF-κBp65和CyclinD1的表达情况。结果:①PTEN在胃腺癌组织中蛋白表达阳性率为42.5%(31/73),明显低于它在正常胃粘膜组织中的阳性表达率90%(18/20)(P<0.01);NF-κBp65和CyclinD1在胃腺癌组织中蛋白表达阳性率分别为58.9%(43/73)和60.3%(44/73),明显高于它们在正常胃粘膜组织中的阳性表达率20%(4/20)和25%(5/20)(P<0.01);②PTEN与胃腺癌组织分化程度呈正相关(P<0.01),与胃腺癌浸润深度、淋巴结转移及临床分期呈负相关(P<0.01或P<0.05);NF-κBp65与胃腺癌组织分化程度呈负相关(P<0.05),与胃腺癌浸润深度、淋巴结转移及临床分期呈正相关(P<0.05或P<0.01);CyclinD1与胃腺癌的浸润深度相关(P<0.05),与组织分化程度、淋巴结转移及临床分期无相关关系;③胃腺癌中PTEN的阳性表达率与NF-κBp65和CyclinD1均呈负相关(P<0.05,P<0.01),NF-κBp65与CyclinD1的阳性表达率呈正相关(P<0.05)。结论:PTEN、NF-κBp65和CyclinD1基因在胃腺癌的发生、发展中起着不同的作用;联合检测PTEN、NF-κBp65和CyclinD1,可能有助于对胃腺癌恶性程度的判定及侵袭转移能力的评估,进而为胃腺癌的预后分析和进一步治疗提供依据。 BACKGROUND & AIM: To investigate the protein expressions of PTEN, NF-κBp65 and CyclinD1 in gastric adenocarcinoma and the relationship between their expressions and clinicolpathological features. MATERIALS AND METHOd: Protein expressions of PTEN, NF-κBp6 and CyclinD1 in paraffin embedded tissues from 73 cases of gastric adenocarcinoma and 20 normal gastric mucosa tissues were analyzed by immunohistochemical method. RESULTS:①The positive rate of PTEN protein expression was 42.5% (31/ 73) in gastric adenocarcinoma, lower than that in normal gastric mucosa tissues 90% (18/20)(P〈 0.01); The positive rates of NF-κBp65 and CyclinD1 protein expression were 58.9% (43/73)and 60.3% (44/73),respectively in gastric adenocarcinoma, higher than those in normal gastric mucosa tissues 20% (4/20)and 25% (5/20), respectively(both P〈0.01); ②The expression of PTEN in well-differentiated adenocarcinoma was higher than that in poorly-differentiated adenocarcinoma (P 〈 0.01) . Also, the loss or decreased expression of PTEN significantly correlated with infiltrative depth, lymph node metastasis and clinicolpathological stage (P〈 0.01 or P 〈 0.05) . Contrary to PTEN, the expression level of NF-κBp65 in poorly-differentiated adenocarcinoma was higher than that in well-differentiated ones(P〈0.05), and the increased expression of NF-κBp65 significantly correlated with infiltrative depth, lymph node metastasis and clinicolpathological stage(P〈0.05 or P〈0.01) .The expression level of CyclinD1 only correlated with infiltrative depth of gastric adenocarcinoma(P〈0.05); ③Significantrelationships were found between FFEN and NF-κBp65 or CyclinDl(P 〈0.05, P 〈0.01), while a positive correlation could also be found between NF-κBp65 and CyclinD1(P 〈0.05) . CONCLUSION: This expreiment suggested that FTEN, NF-κBp65 and CyclinD1 may play certain roles in the oncogenesis and progression of gastric adenocarcinoma, but to different extents. Combined evaluation of FTEN, NF-κBp65 and CyclinD1 may be helpful to assess the malignant degree, treatment and prognosis of gastric adenocarcinoma.
出处 《癌变.畸变.突变》 CAS CSCD 2007年第5期366-369,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
关键词 胃腺癌 PTEN NF-ΚBP65 CYCLIND1 免疫组织化学 LI Peng, YANG Gui-fang, CHEN Jian-ou, HUANG Ka-te,ZHAO Jing ( Department of Pathology, The Frist Affiliated Hospital ofWenzhou Medical College, Wenzhou, 325000 Department of Pathology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China)
  • 相关文献

参考文献2

二级参考文献52

  • 1[1]Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH,Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R,Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362
  • 2[2]Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,Ittmarn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947
  • 3[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129
  • 4[4]Cantley LC, Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240-4245
  • 5[5]Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998; 95:15587-15591
  • 6[6]Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A 1999; 96:6199-6204
  • 7[7]Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases.Annu Rev Biochem 2001; 70: 247-279
  • 8[8]Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
  • 9[9]Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70:829-844
  • 10[10]Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 2001; 61:589-593

共引文献148

同被引文献21

  • 1龙白,张阳德,张洋,刘祥彦.槲皮素脂质体纳米粒对肝癌HepG2细胞生长的抑制作用[J].中国现代医学杂志,2007,17(8):911-913. 被引量:3
  • 2郭庆喜,蒲霞,刘勇,杨成万,周铁军,孙兴旺.大肠癌中PTEN蛋白的表达与微血管生成的相关性[J].泸州医学院学报,2007,30(3):172-175. 被引量:1
  • 3谷化平,尚培中.survivin和PTEN蛋白在大肠癌中的表达及临床意义[J].临床消化病杂志,2007,19(3):176-178. 被引量:3
  • 4Scartozzi M, Bearzi I, Pierantoni C, et al. NF-kB tumor ex- pression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy[ J]. J Clin Oncol. 2007, 25:3930-3935.
  • 5Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences [ J] . Cell, 1986, 46: 705-716.
  • 6May M J, Ghosh S. NF- kappaB and Rel proteins : evolutionarily conserved medators of immune responses[J]. Immunology To- day, 1998,19:80-88.
  • 7May MJ, Ghosh S. I-B kinase: kingmen with different crafts [ J ]. Science, 1999, 284:271-273.
  • 8MaihSfner C, Charalambous MP, Bhambra U, et al. Expression of cyclooxygenase-2 parallels expression of interleukin- 1 beta, interleukin- 6 and NF- Kappa B in human colorectal aneer[ J ]. Carcinogenesis, 2003, 24:665-671.
  • 9Evertsson S, Sun XF. Protein expression of NF- KB in human colorectal adenocarcinoma [ J]. Int Mol Med, 2002, 10:547.
  • 10Tamu M, GU J, Matsumoto K, et al. Inhibition of cell mi- gration, spreading, and focal adhesions by tumor surppressor PTEN [J]. Science,1998, 280: 1614-1617.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部